Press ReleasePosted by Repositive, November 2019Repositive partners with Scientist.com to offer pharma and biotech researchers access to industry-leading directory of preclinical cancer models
Cancer Models ForumPosted by Repositive, November 2019Organoids: The 3D era of cancer drug discovery is here
Press ReleasePosted by Repositive, November 2019Repositive unveils molecular search functionality for its Cancer Models Platform at ELRIG Drug Discovery
Press ReleasePosted by Repositive, October 2019Repositive launches world-leading directory of preclinical cancer models on Science Exchange
Cancer Models ForumPosted by Anna, October 2019How organoids could bridge the gap between in vivo and in vitro preclinical cancer models
Cancer Models ForumPosted by Anna, October 2019What’s the hype about organoids? Here’s 3 ways that organoids could boost your drug development programme
Cancer Models ForumPosted by Terence, September 2019How to revamp your high-throughput screening projects
Press ReleasePosted by Repositive, September 2019Repositive appoints Slaven Stekovic as Head of Strategic Growth and leading commercial advisers to drive the company’s scale-up and global growth ambitions
Cancer Models ForumPosted by Ruth, September 20194 promising therapeutic approaches being developed in the fight against cancer
Cancer Models ForumPosted by Arielle, July 2019Key takeaways from the Milner Therapeutics Symposium 2019
